A MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP TRIAL TO COMPARE THE EFFICACY AND SAFETY OF THE SUFENTANIL NANOTAB PCA SYSTEM/15 MCG (ZALVISO™)TO INTRAVENOUS PATIENT-CONTROLLED ANALGESIA WITH MORPHINE FOR THE TREATMENT OF ACUTE POST-OPERATIVE PAIN: